David B. Vodušek (DBV): Can you tell us about your training and how you ended up looking after neurological patients with uro-neurological symptoms?
David B. Vodušek (DBV): Can you tell us about your training and how you ended up looking after neurological patients with uro-neurological symptoms?
Clare J Fowler (CJF): My early training included neurology at a junior level, but when it came to choosing a career path I was advised to pursue clinical neurophysiology, on the grounds that it could be a 'suitable' job for a woman with children. Furthermore, there was a UK shortage of consultant neurophysiologists.
Increasing Calls for Brain Health Action at High-level New York Event
September 30, 2026
At the Global Brain Coalition’s Brain Days, which took place alongside the 81st United Nations General Assembly (UNGA81) during High-level Week, policymakers, scientists, clinicians, patient advocates and international organisations gathered to discuss how brain health can move higher up the global policy agenda.
First EAN Annual Report Reviews Major Milestones of 2025
August 7, 2026
Latest Posts
-
-
ResearchScientific Corner
Interview with Helen Cross on the European Reference Networks – following the Meeting of the Rare Neurologic Diseases Task Force at EAN 2017
September 4, 2017Antonio Federico: What are the aims of your ERN? Helen Cross: The objectives of the EpiCARE network will be: To improve accessibility of detailed diagnostics to individuals of all ages with rare and complex epilepsies across Europe, including clinical evaluation and investigation. -
A session on neurological palliative care was included within the 15th World Congress of the European Association for Palliative Care in Madrid on 18th May. In 2016, a Memorandum of Understanding was signed between the EAPC and the EAN and… Continue Reading
-
Palliative care has featured again at a session at the 3rd Congress of the European Academy of Neurology in Amsterdam at the end of June 2017. There has been a developing collaboration between the EAN and the EAPC and in… Continue Reading
-
At the Peripheral Nerve Society congress (8-12 July 2017, Sitges, Spain), Professor Satoshi Kuwabara from the Department of Neurology at Chiba University, Japan, announced the results of a randomized placebo-controlled phase 2 trial with eculizumab in patients with Guillain-Barré syndrome.… Continue Reading
-
ResearchScientific Corner
Interview with Teresinha Evangelista on the European Reference Networks – following the Meeting of the Rare Neurologic Diseases Task Force at EAN 2017
August 18, 2017ntonio Federico: What are the aims of your ERN? Teresinha Evangelista: Our MISSION: Through collaborative cross-border work the EURO-NMD ERN will improve the lives of EU citizens by improving diagnosis, treatment and the delivery of high-quality, accessible and cost-effective healthcare to patients with rare Neuromuscular Diseases (NMD) requiring a particular concentration of resources or expertise. -
ResearchScientific Corner
EAN Task Force for Rare Neurological Diseases Teaching Course – 7-9 September 2017, Cluj-Napoca, Romania
August 17, 2017The EAN Rare neurological diseases task force will be holding its 1st teaching course under the auspices of Dafin F. Muresanu, Professor of Neurology at the “Iuliu Hatieganu” University of Medicine and Pharmacy, in Cluj-Napoca, Romania. This teaching course aims… Continue Reading -
Other News
1st Summer School on Neuromodulation for Movement Disorders – a unique experience
August 4, 2017by Antonella Macerollo The first Summer School on Neuromodulation for Movement Disorders was sponsored by the European Section of Movement Disorders (MDS) and took place in Grenoble, France, on July 6-8th 2017. This three-day course encompassed several key lectures from… Continue Reading -
After a very successful congress in Amsterdam with more than 6000 participants, the Editors-in-chief, Elena Moro and Tim von Oertzen interviewed the two persons, responsible for the organisation of the congress, Prof. Paul Boon, chair EAN programme committee and Prof.… Continue Reading
-
The new CME article August 2017: “Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies – a national cohort study” is online now! Please log-in and browse to the LEARN section on the EAN Website and answer… Continue Reading
-
Following the the very well attended lunch session: “Challenges for women in neurology” Elena Moro and Selma Tromp invited the 3 lecturing ladies for a round-talbe discussion. Please read the enitre report on this session, or the follow-up article… Continue Reading
-
During the EAN conference in Amsterdam in June 2017, the symposium on "Challenges for Women in Neurology" had 2 out of 3 invited speakers address aspects African Neurology (Dekker from Tanzania; Charway-Felli from Ghana). That is not a coincidence, as this region has seen significant developments in very recent years.
-
Paper of the MonthFeatured Slider
Paper of the month: Edaravone reduces disability progression in early ALS
August 1, 2017or August 2017, we have selected: The Writing Group on behalf of the Edaravone (MCI-186) ALS 19 Study Group. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial. Lancet Neurol 2017;16:505-512. There is evidence that oxidative stress induced by free radicals is a key factor of progression in amyotrophic lateral sclerosis (ALS). -
EAN Congress newsEducation corner
Amsterdam 2017: 18 years of EAN Spring School – Alumni “Happy Hour”
August 1, 2017During the 3rd Congress of the EAN, an outstanding opportunity of meeting colleagues who took part in previous Spring School meetings was organized. -
It was a pleasure for me to represent the EAN at the 1st EBM meeting in held in Paris (La Salpétrière Hospital) on May 23, 2017. The objective of the EBM project is to preserve and to promote collections of archives related to the History of the various disciplines concerned by brain science (not only neurology, but mostly).









